Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL (Tables)

v3.24.3
SHARE CAPITAL (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

 

    September 30, 2024     September 30, 2023  
Warrants     13,761,493       270,762  
Options     61,567       76,185  
Convertible debentures     22,890,431       2,020,390  
Total anti-dilutive weighted average shares     36,713,491       2,367,337